Medical/Pharmaceuticals

Breakthrough in AML Treatment: GoldenBiotech Reports New Drug Trial of Antroquinonol -Outperforms Listing Drugs in Relapsed Acute Myeloid Leukemia

TAIPEI, Nov. 26, 2020 /PRNewswire/ -- Golden Biotechnology Corp.(GoldenBiotech, 4132.TWO), a leading Taiwanese biopharmaceutical company, announces that its new drug Antroquinonol (HOCENA®) outperforms the other listing drugs for the treatment of relapsed AML (acute myeloid leukemia) patients in ...

2020-11-26 21:35 918

Senhwa Announces Multiple IND Application Submissions to US FDA and Health Canada for the Treatment of Solid Tumors with BRCA2 or PALB2 Mutations

TAIPEI and SAN DIEGO, Nov. 25, 2020 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on next-generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, today announced that it has submitted multiple Investigational New D...

2020-11-26 10:34 590

China Biologic Reports Financial Results for the Third Quarter of 2020

BEIJING, Nov. 24, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced its unaudited financial results for the third quarter of 2020. Third Quarter...

2020-11-25 05:30 5955

NaviFUS highlights clinical trial data and device capabilities at virtual International Focused Ultrasound Symposium

TAIPEI, Nov. 24, 2020 /PRNewswire/ -- The 7th International Focused Ultrasound Symposium organized by the U.S. Focused Ultrasound Foundation took place from 11/9 to 11/13 in virtual format this year due to theCOVID-19 epidemic. During the 5-day conference, participants presented and exchanged inf...

2020-11-24 22:26 585

OliPass Announces Formation of Scientific Advisory Board of Pioneers in Sodium Ion Channellopathy and Pain

SEOUL, South Korea, Nov. 24, 2020 /PRNewswire/ -- OliPass Corporation, a South Korea based biotech specialized in the development of RNA therapeutics, announced to commission a Scientific Advisory Board ("SAB") of key experts in sodium ion channelopathy and pain. The SAB will advise OliPass on th...

2020-11-24 22:00 559

Firestorm Fire Protection PTY Announces Rebranding, Changes Name to United Safety

A leader in the fire protection space has unveiled a new name, logo, and look. EXTON, Pa., Nov. 22, 2020 /PRNewswire/ -- Kristian Bischoff, CEO and Managing Director announced as ofNovember 1st, 2020 that a company-wide rebranding had been completed. "When Firestorm was purchased by United Safe...

2020-11-23 07:00 642

Novel Antioxidant Seen as an Effective Strategy for Peripheral Artery Disease

OMAHA, Ne., Nov.20, 2020 /PRNewswire/ -- Researchers within the School of Health and Kinesiology at theUniversity of Nebraska at Omaha (UNO) have found that a novel antioxidant can provide a number of health benefits for individuals with peripheral artery disease. The antioxidant specifically ta...

2020-11-20 23:07 1460

CARsgen Therapeutics to Present Multiple Myeloma Cell Therapy Data at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition in December

SHANGHAI, Nov. 20, 2020 /PRNewswire/ -- CARsgen Therapeutics, a clinical-stage biopharmaceutical company, today announced that data from its global multiple myeloma program will be presented, including two oral presentations and one poster session, at the 62nd American Society of Hematology (ASH)...

2020-11-20 19:00 1028

Concord Medical Schedules 2020 Annual Meeting of Shareholders

BEIJING, Nov. 20, 2020 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone ...

2020-11-20 17:00 3635

Asian Power Devices: Powering modern technology in an ever-shifting landscape

TAIPEI, Nov. 20, 2020 /PRNewswire/ -- Medical field is a critical market for power supplies-- APD introduces customized power supply solutions for medical equipment  and network equipment. Its systems meet all EMI, temper...

2020-11-20 15:46 547

China Biologic Enters into Definitive Merger Agreement for Going Private Transaction

BEIJING, Nov. 19, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that it has entered into a definitive Agreement and Plan of Merger (the "Merg...

2020-11-19 21:09 7446

VolitionRx Limited to Present COVID-19 Data at MEDICA 2020

AUSTIN, Nov. 19, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases, has announced that Dr.Mark Eccleston, a founding sci...

2020-11-19 20:00 6635

WuXi Advanced Therapies Expands Philadelphia Campus with New State-of-The-Art Testing Laboratory

PHILADELPHIA, Nov. 18, 2020 /PRNewswire/ -- WuXi Advanced Therapies Inc. (WuXi ATU) – a business unit of WuXi AppTec offering end-to-end contract services for the cell and gene therapies industry – today announced the completion of a facility expansion that will triple its advanced testing capaci...

2020-11-18 21:00 480

Samsung Biologics breaks ground on Super Plant, the world's largest and most innovative bio-manufacturing facility

INCHEON, South Korea, Nov. 18, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) officially began construction of its Plant 4 in Incheon,South Korea. Dubbed the "Super Plant," the new, multi-story 238,000-square-meter construction will be the world's largest biopharmaceutical manufacturing ...

2020-11-18 20:00 625

Samsung Biologics announces strategic manufacturing partnership with Lilly to accelerate delivery of COVID-19 antibody treatments

INDIANAPOLIS and INCHEON, South Korea, Nov. 17, 2020 /PRNewswire/ -- Samsung Biologics' partnership with Eli Lilly and Company is expected to greatly accelerate the global supply for Lilly's COVID-19 antibody therapies through a long-term manufacturing agreement, with the ultimate goal of making ...

2020-11-17 20:00 505

Corvia Medical Completes Randomization In REDUCE LAP-HF II Pivotal Trial And Gains FDA Authorization To Provide Continued Access For The Corvia Atrial Shunt

Large randomized, sham-controlled trial evaluates interatrial shunting in a heart failure population currently without effective treatment TEWKSBURY, Mass., Nov. 17, 2020 /PRNewswire/ -- Corvia Medical, Inc., a company dedicated to transforming the treatment of heart failure (HF), today announce...

2020-11-17 19:00 433

Foresee Pharmaceuticals Enters Exclusive License Agreement with GenSci for the Commercialization of Camcevi(TM) in China

TAIPEI, Nov. 17, 2020 /PRNewswire/ -- Foresee Pharmaceuticals (6576.TWO) ("Foresee") announced today that it has entered into an exclusive license agreement with GenScience Pharmaceuticals ("GenSci") - a wholly-owned subsidiary of Changchun High-Tech Industry (Group) Co., Ltd. (000661.SZ) - for ...

2020-11-17 17:51 699

CPhI & P-MEC China 2020 adapts to customer needs with hybrid pharma event

SHANGHAI, Nov. 17, 2020 /PRNewswire/ -- CPhI & P-MEC China returns as a hybrid event in Shanghai (16-18 December, 2020), with a physical exhibition running alongside Virtual Expo Connect

2020-11-17 15:00 473

Big Bets on Wuhan: United Imaging "at Full Steam" to Support Health Industry Upgrade

WUHAN, China, Nov. 16, 2020 /PRNewswire/ -- Wuhan, the epicenter of the COVID-19 outbreak, now stages an epic comeback as the second World Health Expo 2020 opens here onNov. 11, 2020. Industry thought leaders, including Margaret Chan Fung Fu-chun, former Director-General of WHO, Nobel laureates i...

2020-11-17 09:12 619

Alterity announces approval of US patent for next generation compounds to treat neurodegenerative diseases

MELBOURNE, Australia, Nov. 16, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has today announced the allowance of a new composition of matter patent by the United States Patent and Trademark Office (USPTO). The new patent is the product of in-ho...

2020-11-16 21:42 1979
12345 ... 246